Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Get the latest Septerna, Inc. (SEPN) stock news and headlines to help you in your trading and investing decisions.

There are hundreds of conditions that have itch as an underlying symptom, according to Brian S. Kim, MD, MTR, the Sol and ...

Advancements in itch therapeutics have evolved rapidly, offering patients with various itch-driven diseases multiple options ...

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native ...

Septerna, Inc. ( (SEPN) ) just unveiled an announcement.